Workflow
红日药业(300026) - 2025 Q1 - 季度财报
300026Chase Sun(300026)2025-04-27 07:41

Financial Performance - The company's revenue for Q1 2025 was ¥1,392,772,566.61, a decrease of 4.82% compared to ¥1,463,378,271.09 in the same period last year[5] - Net profit attributable to shareholders was ¥60,329,743.62, reflecting a 3.80% increase from ¥58,120,874.65 year-on-year[5] - Total operating revenue for the current period is ¥1,392,772,566.61, a decrease of 4.8% from ¥1,463,378,271.09 in the previous period[21] - Net profit for the current period is ¥61,884,708.86, an increase of 13.7% compared to ¥54,398,108.68 in the previous period[22] - Total operating costs for the current period are ¥1,309,581,769.19, down 4.2% from ¥1,367,139,489.84 in the previous period[21] - Other comprehensive income after tax for the current period is ¥126,095.49, compared to a loss of ¥422,152.76 in the previous period[23] - The total comprehensive income for the current period is ¥62,010,804.35, an increase from ¥53,975,955.92 in the previous period[23] Cash Flow - The net cash flow from operating activities decreased by 24.47% to ¥103,952,295.10 from ¥137,623,131.48 in the previous year[5] - Cash inflow from operating activities is ¥1,468,822,592.88, a decrease from ¥1,503,435,403.84 in the previous period[25] - Cash outflows from operating activities totaled $1,364,870,297.78, remaining relatively stable compared to $1,365,812,272.36 last year[26] - The net cash flow from investing activities was -$42,862,870.22, an improvement from -$48,575,252.14 in the previous period[26] - Cash inflows from financing activities were $1,439,920.09, significantly lower than $10,694,044.17 in the prior year[26] - The net cash flow from financing activities was -$164,403,487.18, worsening from -$37,020,439.30 in the previous period[26] - The total cash and cash equivalents at the end of the period were $1,170,382,482.29, down from $1,599,338,522.53 at the end of the previous period[26] Assets and Liabilities - Total assets at the end of the reporting period were ¥11,027,171,551.76, down 1.24% from ¥11,165,116,699.53 at the end of the previous year[5] - Total liabilities amount to ¥2,166,605,224.24, a decrease of 8.5% from ¥2,366,561,176.36 in the previous period[21] - Total current liabilities decreased to CNY 1,509,592,767.12 from CNY 1,621,148,001.05, a decline of about 6.9%[18] - Short-term borrowings decreased significantly from CNY 16,239,838.57 to CNY 11,454,471.14, a reduction of approximately 29.1%[18] - The total non-current assets decreased to CNY 4,942,907,856.61 from CNY 5,016,065,386.58, reflecting a decline of about 1.5%[18] Shareholder Information - The number of ordinary shareholders at the end of the reporting period was 102,897, with the largest shareholder holding 22.24% of the shares[12] - The company reported a total of 263,602,455 shares subject to lock-up at the end of the period, an increase from 240,731,655 shares at the beginning[15] - The company has not disclosed any significant changes in the relationships or actions among the top shareholders[13] Other Financial Metrics - The weighted average return on equity increased to 0.70%, up from 0.67% in the same period last year[5] - Financial expenses decreased by 61.79% to ¥3.96 million, primarily due to reduced interest expenses[9] - The company reported a significant increase in other income, which rose by 40.91% to ¥1,028.93 million due to increased government subsidies[9] - Research and development expenses increased to ¥47,479,993.23, up from ¥44,359,218.24 in the previous period, reflecting a focus on innovation[22] - Cash outflows for employee compensation amounted to $268,565,434.64, an increase from $241,962,749.42 last year[26] - Tax payments totaled $148,305,973.39, slightly up from $141,228,651.82 in the previous period[26] - The impact of exchange rate changes on cash and cash equivalents was $573,452.99, contrasting with -$186,216.70 in the previous period[26] Strategic Developments - The company has not reported any new strategies or significant developments in product or technology during this period[16]